u/Pure_Evidence638

VT and Chill and Diworsification is what I constantly read here.

This is a perfectly great approach for the average Joe, don’t get me wrong! But with a minimum of reading and understanding of industries and financial statements, you can do it much better.

This may sound (and it is!) an effort for the average Joe, but what I found surprising is that even the “finance professionals” (please allow me a series of ?????).. use the same VT and chill strategy.

And those people -both the average Joe and the financial professional- are the ones that spend two hours to buy hiking equipment, but are not willing to spend 15 minutes reading and end of the year report of a company.

Why is that? Fear or lack of understanding of what opportunity cost means in investing?

Concrete examples:

People felt threatened and insecure on putting 30/40 K in Microsoft last month, when the stock was at$350.. and went up 20/25% in a week after the earnings.

Same thing happened with Amazon, or the past year with GE…

Additionally, you can play and try to find good companies that can be multi baggers over the years.. even if you are right six times out of 10, the return will be enormous!
——-

Please downvote me, but the approach most of people are speaking (the VT chill) will have a massive opportunity cost in 20/30/40y from now!

Small addition for the tiny percentage of people who are slightly more financially educated compared to the average Joe: you can argue that not many professionals are capable to beat the market long run, even in investment funds.

That’s absolutely true, but for a very clear reason!

You will never be blamed -as amanager in an investment fund - if the big company that you recommended to a client will not perform well that year. You will only say “wtf the company XYZ is doing, they have a terrible board..”. But if in the same position you suggest a smaller and largely unknown company, and that company has problems, you will probably be fired!

That -and the need of moving billions around- prevent professional professionals to have spectacular gains over a year. Small investors have much more freedom! Let’s use it.

For context, I have a STEM PhD (very appetibile for big Pharma) + 4y experience in biotech (from clinical to BD&L and portfolio strategy) + finance EMBA with very deep base on financial models.

My idea is to target MBB for 2y in order to broaden my experience toward different companies and then transition into higher role in BigPharma.

I have - I would say- good understanding of strategy in general (not bs books, but rather Porter’s strategy).

I have good case understanding as I always liked using the frameworks you guys use as a base to solve daily problems and give recommendations.

We hired IQVIA/ McKinsey and BAIN and i can flag the issue in their approach (I.e. no clue about rules/regulations + very basic assumptions in DCF calculations.. which might work for IB, but not for Pharma). Here is where I can create value = real experience across drug development value chain.

What stops me:

1. ⁠being perceived as a sales guy from industry leaders, with no P&L accountability (crucial for director + level).
2. ⁠Have 30yo bosses that have zero experience in industry and thus zero leverage (beside company’s name) with the clients.
3. ⁠Big companies are valuing less and less external consultancy, because they are figuring out that most of the (very general) job is done by 1-2 people that can be hired internally. This allows the firm to:

a) keep the expertise in house and available immediately
b) tailor the expertise to the firm’s pipeline and culture.

That being said:

- are MBB interested in my profile?

- is it worth for me to commit to consultancy for 2y or better go toward an industry position?

- is there anything I missed to consider?

Thanks

For context, I have a STEM PhD (very appetibile for big Pharma) + 4y experience in biotech (from clinical to BD&L and portfolio strategy) + finance EMBA with very deep base on financial models.

My idea is to target MBB for 2y in order to broaden my experience toward different companies and then transition into higher role in BigPharma.

I have - I would say- good understanding of strategy in general (not bs books, but rather Porter’s strategy).

I have good case understanding as I always liked using the frameworks you guys use as a base to solve daily problems and give recommendations.

We hired IQVIA/ McKinsey and BAIN and i can flag the issue in their approach (I.e. no clue about rules/regulations + very basic assumptions in DCF calculations.. which might work for IB, but not for Pharma). Here is where I can create value = real experience across drug development value chain.

What stops me:

1. being perceived as a sales guy from industry leaders, with no P&L accountability (crucial for director + level).

2. Have 30yo bosses that have zero experience in industry and thus zero leverage (beside company’s name) with the clients.

3. Big companies are valuing less and less external consultancy, because they are figuring out that most of the (very general) job is done by 1-2 people that can be hired internally. This allows the firm to;

a) keep the expertise in house and available immediately
b) tailor the expertise to the firm’s pipeline and culture.

That being said:

- are MBB interested in my profile?

- is it worth for me to commit to consultancy for 2y or better go toward an industry position?

- is there anything I missed to consider?

Thanks

Thinking about selling some win from S&P ETF and buy one of the two, possibly for the next 5Y.

Are they well positioned to beat the market?

Alternative is to buy GEV, which I believe cold be successful in the next 5Y and -possibly- more recession proof than tech.

Another alternative: KO

Any suggestion is appreciated

Energy is a topic that always fascinates me not because of weird intrinsic reason, but because it represents the future of mankind.

That’s it, I believe that nuclear is probably the source of energy that we will certainly develop in the next 5 to 10 years. What is the difference from before? The desperate need that we have now, and for “ we” I mean the big companies that run the world.

Data centres are popping up like flowers in spring.

Obviously, there are ordinary energy company that are trying to keep up and supply energy, but I doubt that this will be sustainable long run.

The company that will lead the AI revolution will be needed to shrunk costs at some point in order to maintain the market share, since the two more costly part of the data centres are the chips and the energy, and since for cheap making Chinese advancing quite fast, energy is the other big thing that will need to be optimised.

I firmly believe that nuclear is the only energy that will allow to cut cost, at least in the long run (20+y).

That’s sad, I ask you expert opinion on which listed companies in US, Europe, Asia are advancing toward this goal

Energy is a topic that always fascinates me not because of weird intrinsic reason, but because it represents the future of mankind.

That’s it, I believe that nuclear is probably the source of energy that we will certainly develop in the next 5 to 10 years. What is the difference from before? The desperate need that we have now, and for “ we” I mean the big companies that run the world.

Data centres are popping up like flowers in spring.

Obviously, there are ordinary energy company that are trying to keep up and supply energy, but I doubt that this will be sustainable long run.

The company that will lead the AI revolution will be needed to shrunk costs at some point in order to maintain the market share, since the two more costly part of the data centres are the chips and the energy, and since for cheap making Chinese advancing quite fast, energy is the other big thing that will need to be optimised.

I firmly believe that nuclear is the only energy that will allow to cut cost, at least in the long run (20+y).

That’s sad, I ask you expert opinion on which listed companies in US, Europe, Asia are advancing toward this goal?

genuine question.

i am trying to purchase some companies I believe in, but the volatility is high and risk even higher… and many of them will not beat the market in 5/10Y anyway.

so I am asking myself: what’s the point?

I think that 99.9% of people here never beaten the market for 5-7 consecutive years (which is what many hedge funds do not do anyway..) so - genuinel- what’s the point?

can normal people be smarter than Wall Street IB? mostly not, or we will probably work as MD at Goldman and not write here..

what‘s your take?

edit: got it, people are pretentious and over optimistic.

but then what about the dearest Warren? He did not beat the market over the last 10-15y Because of tech… but losing 10-15y is quite a lot of time..

having 10k to drop, should I buy GE, Nvidia, Amazon, TSMC, ASML?

I have a 3-4Y horizon, i am fine with fluctuation.

now I have my largest position in Microsoft (down 10%!).

Hi all,

I’ve been riding some massive gains in short time in NVIDIA and GE (both up over 50% for me), and I’m now at the point where I need to rebalance and take some profits off the table. My plan is to trim these positions and redeploy that capital into other high-conviction names, ideally staying within the tech sector since that’s where I have the most conviction and understanding.

The core question I’m wrestling with is where to put that money to work for the next five years with the goal of outperforming the broader market. I’m not looking to just match the S&P 500 — I’m willing to take on more volatility and risk in exchange for outsized returns, as long as the thesis is solid.

Right now, the names I’m considering are: Microsoft, Google (Alphabet), Nebius, Palantir, Micron, and Marvell.

I’d love to get the community’s deeper take on each of these, especially through a 5-year lens. A few specific thoughts and questions on each:

· Microsoft — The Azure and AI narrative is obviously powerful, and Copilot integration across the enterprise stack seems like a genuine multi-year growth driver. But at this market cap, can it realistically double or more in five years, or is it becoming a safer but lower-upside compounder at this stage? Are we reaching a point where the law of large numbers kicks in meaningfully?

· Google (Alphabet) — The valuation is more reasonable than many peers, and they have arguably the deepest AI research bench in the world. But I worry about the existential risk to search from AI answer engines, regulatory overhang, and whether they can actually monetize AI without cannibalizing their core business. Do you see YouTube and Cloud carrying enough weight to offset any search headwinds over a half-decade horizon?

· Nebius — This is the one I know the least about and would especially appreciate insight on. It seems to be positioning itself as a leading AI cloud infrastructure provider, heavily linked to the former Yandex team. The growth story sounds compelling, but liquidity, corporate structure, and geopolitical ties concern me. Is this a legitimate high-growth AI infrastructure play or more of a speculative bet that could just as easily go to zero?

· Palantir — The commercial acceleration story is finally playing out, and AIP seems like a real product that enterprises actually want. But the valuation has run up so much that I’m struggling to figure out how much future growth is already priced in. Is there a realistic path to $100B+ in annual revenue in 5 years, or are we in hype territory where even great execution won’t justify the current multiple?

· Micron — Memory is brutally cyclical, but the long-term thesis around HBM (high-bandwidth memory) and AI-driven demand seems structurally different this time. Is Micron the best non-GPU way to play the AI buildout over five years, or will the cycle inevitably turn and wipe out a big chunk of these gains? How do you handicap the cycle timing risk versus the secular demand story?

· Marvell — Their pivot to custom AI silicon and data infrastructure is super interesting, and their design wins in optical connectivity and ARM-based computing give them a different angle than NVIDIA. But this is complex silicon IP — execution risk is real, and they’re competing with Broadcom and others. Can Marvell carve out a big enough niche to deliver market-beating returns over a full five-year cycle?

Beyond these specific names, I’m also wondering if I’m thinking too narrowly by focusing on these larger, already well-known names. Should I be spending more time looking at smaller-cap companies where the growth runway and potential multiples expansion could be much more explosive? Smaller names can obviously deliver life-changing returns in a way that a $3 trillion company simply can’t, but the failure rate is also exponentially higher.

As a reference point, I do hold Amprius (AMPX) as a long-term speculative bet because I believe their silicon anode battery technology could be transformative if they can scale manufacturing. I’m comfortable with that kind of risk/reward profile for a portion of my portfolio. Would love suggestions on other smaller names that people feel have similarly disruptive potential over a 5-year time horizon — whether in AI infrastructure, energy storage, space, biotech, or any other tech-adjacent space. I’m particularly interested in companies that have already de-risked the technology somewhat and are now in the commercial scaling phase, rather than pure pre-revenue lottery tickets.

So my questions to the community, in summary:

1. Of the six names I listed (MSFT, GOOGL, Nebius, PLTR, MU, MRVL), which do you have the highest 5-year conviction in for beating the market, and why? Which would you avoid?
2. Is now actually a good time to deploy fresh capital into any of these, given where valuations are across the AI/tech landscape, or should I consider holding some cash and waiting for a pullback?
3. Should I tilt my portfolio toward smaller, higher-growth companies for the next five years rather than these mega and large-cap names? If so, what are your best small-cap ideas with truly disruptive potential?

Appreciate any and all thoughtful responses — especially from those who have deep knowledge of these companies or the specific sub-sectors they operate in. Thanks in advance.

Hi all,

I have to allocate some money from nvidia and Ge (up >50%) to other companies, ideally in tech.

What about MICROSOFT, GOOGLE, NEBIUS, PALANTIR, MICRON, MARVELL?

Will they beat the market in the next 5Y?

Is it better to look at other smaller companies ? (I own AMPX as long term bet).

Thanks